Similarly, normalizing blood glucose with the sodium/glucose cotransporter 2 inhibitor, empagliflozin, which promotes urinary excretion of glucose to attenuate hyperglycemia, was shown to directly promote β-cell recovery, including repopulation of the mature insulin secretory granule pool [188]. This evidence concerns the gene INS and Hyperglycemia.